|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02211 UNI HEALTH
Nominal 
0.118 +0.011 (+10.280%) | 2023/12 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 591,339 | -25.802% | 796,976 | 616,693 | 587,427 | 1,066,797 |
| Cost of Sales | (495,157) | -25.358% | (663,376) | (526,818) | (520,823) | (926,938) |
| Gross Profit | 96,182 | -28.007% | 133,600 | 89,875 | 66,604 | 139,859 |
| 2023/12 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | (10,433) | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 662 | -- | (6,727) | (499) | 5,180 | 5,969 | |
| Profit / (Loss) before Taxation | (22,501) | -49.208% | (44,300) | (125,753) | (254,678) | (170,966) | |
| Taxation | 1,617 | -- | 0 | 0 | (2,819) | 195 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (45) | -- | 69 | 241 | 280 | 340 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (20,929) | -52.683% | (44,231) | (125,512) | (257,217) | (170,431) | |
| 2023/12 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 2,166 | -- | (4,226) | 1,400 | 10,692 | (3,463) |
| Depreciation & Amortisation | 7,107 | -20.209% | 8,907 | 20,474 | 58,196 | 17,794 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2023/12 - Interim | %Chg (Compare to Interim) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2023/12 - Interim | %Chg (Compare to Interim) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | -3.140 | -60.503% | -7.950 | -31.040 | -66.580 | -44.290 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.482 | -- | 0.646 | 1.008 | 2.569 | 4.079 |
| Remarks: | Real time quote last updated: 28/11/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 413 |
| %Change | -- |
| EPS / (LPS) | RMB 0.001 |
| NBV Per Share (¥) | RMB 0.440 |